The Potential of Immunotherapy in TNBC

May 3, 2017
Elizabeth A. Mittendorf, MD, PhD

Elizabeth A. Mittendorf, MD, PhD, associate professor, department of surgical oncology, University of Texas MD Anderson Cancer Center, discusses the promise immunotherapy has shown thus far in breast cancer, particularly triple-negative breast cancer (TNBC).